Actively Recruiting

All Genders
Healthy Volunteers
ID04852354

Tissue Collection for Drug Screening and Bioanalysis of Central Nervous System Tumors

Led by Weill Medical College of Cornell University ยท Updated on 2025-12-17

500

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are studying central nervous system (CNS) tumors to gain a better understanding of their characteristics. This observational study collects tissue samples from patients with CNS tumors during surgery and post-mortem to develop tumor cell lines and models. The goal is to test how these tumors respond to various drugs, which may lead to new treatment options and identification of therapy targets. Samples collected include tumor tissue, blood, cerebrospinal fluid, saliva, skull, and dura from patients undergoing neurosurgery. Saliva samples are also collected from parents of pediatric tumor patients. In addition, blood and cerebrospinal fluid samples are taken from patients without tumors undergoing neurosurgery. Post-mortem donations include whole brain, spinal cord, biofluids, and skin biopsies from brain tumor patients. These samples support various analyses such as DNA/RNA sequencing, proteomics, immunoprofiling, and drug screening. Participants provide biological samples during their routine surgical procedures or through autopsy donation. Researchers analyze the genetic, immunohistochemical, cellular, and molecular profiles of the tumor samples over an average of 1 to 3 years. Additional samples from parents and non-tumor patients help with comparisons. This study involves no interventions but focuses on detailed tissue analysis to improve CNS tumor research and future therapies.

CONDITIONS

Brief Title

Tissue Collection for Drug Screening and Bioanalysis

Who Can Participate

All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Subject has a suspected or confirmed neoplastic CNS lesion and is undergoing neurosurgery with tissue removal
  • Tissue available beyond diagnostic needs during surgery
  • Subjects of all ages, including neonates (0-4 weeks) and pregnant individuals, are included
  • Non-tumor subjects between 4 weeks and 21 years undergoing neurosurgery without CNS tumor diagnosis
  • Biological parents of patients enrolled in tumor neurosurgery cohort and not pregnant at enrollment
  • Subjects diagnosed with neoplastic CNS lesions at time of passing for autopsy donation
Not Eligible

You will not qualify if you...

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Tissue Collection During Neurosurgery

Duration - Occurs on the day of surgery

Participants undergoing routine neurosurgery provide tissue and biological samples such as tumor tissue, blood, cerebrospinal fluid, saliva, skull, and dura for research purposes if extra tissue is available.

1 surgical collection visit (in-person)

Autopsy Donation

Duration - Occurs post-mortem

Post-mortem biospecimens including whole brain, spinal cord, biofluids, and skin biopsy are collected from participants who donate tissue after passing.

1 collection visit (post-mortem)

Sample Analysis and Monitoring

Duration - Up to 3 years

Collected samples undergo various analyses such as DNA/RNA extraction, sequencing, methylome analyses, proteomic analysis, immunoprofiling, and primary culturing to support research.

Trial Site Locations

Total: 1 location

1

Weill Cornell Medicine

New York, New York, United States, 10021

Actively Recruiting

Loading map...

Research Team

J

Jeffrey Greenfield, M.D.

P

Pediatric Neurosurgery

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

4

Similar Trials

Machine Learning Model-Based Risk Stratification to Reduce S...

Surgical Site Infection (SSI)

Actively Recruiting

1 location

Multi-Center Phase I Study of Avutometinib (VS-6766), a RAF/...

Refractory Cancer

Actively Recruiting

2 locations

A Feasibility Study to Determine if a Novel Patient-derived ...

Central Nervous System Tumor

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial